Active ingredientFlunitrazepamCat. No. P-F083-001CAS 1622-62-4Family · Pharmaceutical analytical standards
Flunitrazepam
A hypnotic benzodiazepine that came out of research led by chemist Leo Sternbach, patented in the early 1960s and in clinical use since the 1970s for severe insomnia and to assist with anaesthesia. This family brings together the active ingredient, pharmacopoeial impurities, metabolites and other impurities.
Did you know?Its name sums up its structure: it is the fluorinated N-methyl derivative of nitrazepam, hence 'flu' plus 'nitrazepam'.
Go to the active ingredient →Active ingredientFlunitrazepamCat. No. P-F083-001CAS 1622-62-4
Pharmacopoeial impurityFlunitrazepam EP Impurity ACat. No. P-F083-002CAS 894-76-8
Pharmacopoeial impurityFlunitrazepam EP Impurity BCat. No. P-F083-003CAS 2558-30-7
Pharmacopoeial impurityFlunitrazepam EP Impurity CCat. No. P-F083-004CAS 2512213-47-5
Pharmacopoeial impurityFlunitrazepam EP Impurity DCat. No. P-F083-005CAS 735-06-8
Metabolite7-AminoflunitrazepamCat. No. P-F083-006CAS 34084-50-9
ImpurityFlunitrazepam Impurity 1 (Mixture of Z and E isomers)Cat. No. P-F083-007No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceFlunitrazepam CRSEDQM code F0190000Family FlunitrazepamNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.